News Center

Shenzhen has added the H7N9 avian influenza virus to its surveillance list.

Southern Daily News (Reporters: Xiang Yuhang, Deng Xiang) — H7N9 avian influenza is a novel strain of avian influenza that was first detected in late March 2013 in Shanghai and Anhui. This new subtype of influenza virus represents the first-ever discovery of its kind worldwide. Yesterday morning, the Shenzhen Center for Disease Control and Prevention held a press conference to announce that no cases of H7N9 influenza have yet been identified among the local population in Shenzhen. Since the beginning of this year, influenza-like illness cases in Shenzhen have remained within normal ranges, and there has been no significant increase in the number of pneumonia patients admitted to hospitals across the city. According to reports, the CDC has added this newly identified virus to its nationwide influenza surveillance program, and the center is urging residents to avoid contact with—and consumption of—dead birds and livestock when visiting outdoor areas during the Qingming Festival. No Significant Increase in Pneumonia Hospitalizations According to influenza surveillance data collected since the start of this year, the percentage of outpatient visits presenting with fever and influenza-like symptoms at sentinel hospitals across the city currently stands at around 3.6%–4%, slightly lower than the typical percentage observed during this same season in previous years. Ma Hanwu, Deputy Director of the Shenzhen Center for Disease Control and Prevention, revealed that the number of hospital admissions due to pneumonia has also not increased significantly, with each week seeing only 10–20 pneumonia patients admitted to hospitals throughout Shenzhen. Starting in March each year, the incidence of influenza in Shenzhen begins to rise as the flu becomes more active. Years of influenza surveillance data from Shenzhen show that the peak influenza season typically occurs between May and July. At present, the disease control authorities have established 39 surveillance sites—including hospitals, community health centers, schools, poultry farms, and wholesale markets—where influenza viruses are sampled and tested weekly to keep track of the latest influenza trends. Ma Hanwu noted that human infections with H7N2 and H7N3 avian influenza viruses have been reported in countries such as the Netherlands and Italy; however, H7N9 remains the world’s first documented case. He cautioned the public that while H7N9 avian influenza is concerning, it is not yet cause for widespread panic, as human infections remain rare—this virus primarily circulates among birds rather than humans. He explained that scientists still do not fully understand how this virus might infect humans, but the current approach is to promptly report, investigate, treat, and study any confirmed cases involving infected animals or people. “Shenzhen boasts an excellent influenza testing platform and a high level of research expertise, enabling us to contain outbreaks at their earliest stages.” With the Qingming Festival approaching, Ma Hanwu reminded residents to take care when visiting cemeteries or enjoying spring outings in the countryside: children should be taught to avoid contact with animals, and anyone who discovers dead birds or poultry must report the findings to the relevant authorities—under no circumstances should such animals be handled privately, let alone slaughtered and consumed. Meat and poultry products purchased from certified, quarantined sources can be safely prepared according to hygienic standards without compromising their suitability for ordinary consumption. He also advised citizens to strengthen their immune systems by receiving routine vaccinations. Influenza Surveillance at Shenzhen Ports Has Not Yet Detected Any Abnormalities The reporter also learned that the Shenzhen Inspection and Quarantine Bureau will closely monitor the evolving epidemic situation, conducting influenza surveillance at all Shenzhen ports while intensifying temperature checks and medical inspections of inbound and outbound travelers. Should any suspected infectious disease outbreaks be detected, they will be promptly reported and appropriate measures taken. In addition, the bureau will focus on using electronic display screens, bulletin boards, and notice boards—among other channels—to provide regular updates on the ongoing H7N9 avian influenza outbreak, offering targeted education on preventive measures. Dedicated consultation stations will be set up to provide inbound and outbound travelers with essential health advice and guidance. In recent times, the bureau has conducted comprehensive inspections of port-based temperature monitoring equipment, as well as the stockpiles of protective gear and disinfectants. Meanwhile, staff will remain on standby, ensuring smooth communication and timely reporting in the event of sudden outbreaks. The bureau will also continue to maintain open lines of communication with local health authorities and their counterparts in Hong Kong and Macao, ensuring that the port quarantine joint prevention and control mechanism operates effectively. From January to March this year, Shenzhen port quarantine officials identified 1,962 inbound and outbound travelers exhibiting symptoms such as fever and runny nose, with 299 cases diagnosed as influenza—but no H7-type A influenza was detected. Thus far, influenza surveillance at Shenzhen ports has not revealed any abnormalities. ■Tips for Preventing Influenza 1. Pay Attention to Nutrition and Hygiene: Regular handwashing, frequent ventilation of indoor spaces, proper nutrition, and maintaining good physical condition all help prevent influenza and other respiratory infectious diseases. 2. Avoid Infecting Others: When experiencing respiratory symptoms such as sneezing or coughing, cover your mouth and nose with a tissue or handkerchief. 3. Seek Medical Care When Symptoms Appear: If you develop acute respiratory symptoms such as fever or cough—especially if you experience high fever or difficulty breathing—seek medical attention promptly. 4. Avoid Contact with Pathogens: Refrain from touching or consuming sick (or dead) birds and livestock. (Original Title: H7N9 Avian Influenza Virus Added to Surveillance List)

Source:

Views:

357

29

2020-07

The Connection Between Millimeter Wave Therapy and the Nobel Prize

On October 7, the 2013 Nobel Prize in Physiology or Medicine was announced in Sweden, with American scientists James E. Rothman and Randy W. Schekman, along with German scientist Thomas C. Südhof, jointly awarded the prize. Their groundbreaking research unveiled the mysteries behind how cells organize their transport systems—the process known as “vesicular trafficking.” In the course of this discovery, the three scientists—James E. Rothman, Randy W. Schekman, and Thomas C. Südhof—unveiled the intricate structure and precise regulatory mechanisms underlying the cell’s intracellular transport system. When this system becomes unstable, it can lead to detrimental consequences, such as neurological disorders, diabetes, or immune system dysfunction. Specifically, cells are living entities that rely on external energy and information to maintain their active state. Consequently, the efficient transport of nutrients between cells is crucial for cellular metabolism; if information and energy are not replenished in a timely manner, cells may undergo pathological changes, triggering a cascade of human diseases. Millimeter wave therapy works by resonating with cellular proteins and modulating ion channels, ensuring that communication and interactions between cells remain normal. By activating immune system cells, millimeter wave therapy causes their cell membranes to resonate and absorb millimeter wave energy, thereby establishing a weak alternating electric field. This field influences the permeability of ions across cell membranes—both inside and outside the cell—and even regulates the opening and closing of ion channels. It enhances the cells’ ability to resist lipid peroxidation, increases the activity of immune cells, and promotes immune responses involving both cells and body fluids, ultimately strengthening the body’s capacity to eliminate functional impairments. Through resonance, millimeter waves can realign the microscopic structures within body tissues and alter the activity of proteins, amino acids, and enzymes. As a result, they regulate cellular metabolism and function, improving nutrient supply and metabolic processes in cellular tissues while boosting tissue function and cellular regenerative capacity. Millimeter waves also accelerate the elimination of pathological and metabolic byproducts, enhancing the body’s stress response and non‑specific immune defenses. This year’s Nobel Prize has shed light on the mechanisms underlying cellular communication and underscored its critical importance for human health. Millimeter wave therapy has long been dedicated to promoting cellular health and thereby improving various bodily functions—and the awarding of this Nobel Prize serves as powerful validation for millimeter wave therapy. The transport of nutrients between cells is essential for cellular metabolism; when information and energy are not replenished in a timely manner, cells can become dysfunctional, leading to a range of human diseases. Therefore, at the root of treating human disease lies the treatment of diseased cells—and millimeter wave therapy is precisely a treatment that targets the cellular level. By resonating with cellular proteins and regulating ion channels, millimeter wave therapy ensures that communication and interactions between cells remain normal. This year’s Nobel Prize has revealed the mechanisms of cellular communication and highlighted its significance for human health. Millimeter wave therapy has consistently focused on promoting cellular health and improving overall bodily functions—and the Nobel Prize serves as important validation for this therapeutic approach.

Source:

Views:

286

29

2020-07

Israeli research has found that millimeter-wave radiation can inhibit the regeneration of cancer cells.

China Broadcasting Network, Beijing, March 29 (Reporter Feng Ganyong, Correspondent Chang Liang) — According to recent reports from numerous authoritative media outlets worldwide, Israeli researchers have discovered that irradiating cancer cells with millimeter waves can inhibit their regenerative capacity without damaging the cells themselves. This groundbreaking finding has opened up a new avenue for radiation therapy in cancer treatment. At the recently concluded 3rd International IEEE Conference on Microwave, Communications, Antennas, and Electronic Systems held in Tel Aviv, researchers from Ariel University in Israel announced this discovery, noting that their research has already received funding from relevant European institutions. Professor Yachrom of Ariel University stated that when they exposed lung cancer cells to millimeter waves, they found that the cancer cells lost their ability to regenerate—while healthy cells remained unaffected. “This is undoubtedly tremendous news for cancer radiation therapy,” he added. Yachrom explained that the radiation currently used in cancer treatment is ionizing radiation, which not only kills cancer cells but also damages other cells. “We opted for non-ionizing millimeter-wave radiation, which only disrupts certain cellular functions rather than the cells themselves.” Unlike visible light and microwaves, millimeter waves are more challenging to generate—but with advances in technology, the difficulty involved is steadily decreasing. As Director of the Free-Electron Laser Laboratory at the university, Yachrom and his colleagues employ specialized magnetic structures and electron acceleration techniques to produce these millimeter waves. The research teams from Israeli and Danish universities have received funding from the Eva Henri Foundation in Denmark. Experts in the field have hailed the significant breakthrough in using millimeter waves to treat cancer as a major contribution to humanity.

Source:

Views:

353

29

2020-07

The National Health and Family Planning Commission requires all Grade III hospitals to use exclusively domestically produced medical devices.

The National Health and Family Planning Commission and the Ministry of Industry and Information Technology jointly convened a conference to promote the development and application of domestically produced medical devices. Li Bin, Director of the National Health and Family Planning Commission, stated that the focus will be on encouraging Grade III Class A hospitals to adopt domestically manufactured medical equipment. By accelerating the development of domestic medical devices, expanding their widespread use, leveraging the comparative advantages of Chinese enterprises, reducing healthcare costs, effectively curbing the unreasonable rise in medical expenses, and genuinely easing the financial burden on patients. Li Bin, Director of the National Health and Family Planning Commission, emphasized that advancing the development and application of domestically produced medical devices is an urgent imperative for deepening reform of the pharmaceutical and healthcare systems and for lowering healthcare costs. By speeding up the development of domestic medical devices, promoting their broader adoption, capitalizing on the competitive strengths of local enterprises, reducing medical expenses, effectively stemming the unchecked increase in medical costs, and truly alleviating the financial burden on patients, we can make significant progress. Li Bin noted that the National Health and Family Planning Commission has consistently prioritized the promotion and application of domestically produced medical devices as a key area of work, ensuring that this effort is carried out with diligence and effectiveness. The health and family planning authorities are working closely with the Ministry of Industry and Information Technology to accelerate efforts to overcome barriers hindering the development and application of domestic medical devices, while fostering a favorable social and policy environment. Li Bin stated that it is essential to vigorously encourage healthcare institutions to utilize domestically produced medical devices, with a particular emphasis on driving the adoption of such equipment in Grade III Class A hospitals. By harnessing market competition, we can drive overall improvements in the quality of domestic medical devices and continuously enhance their performance. Miao Wei, Minister of the Ministry of Industry and Information Technology, pointed out that China’s medical device industry has experienced sustained, rapid growth in recent years, with the industry’s scale steadily expanding. A comprehensive industrial system has taken shape—characterized by complete specialized categories, a fully integrated industrial chain, and a continually optimized product structure. By the end of 2013, the total sales revenue of enterprises above designated size had reached 328.7 billion yuan, representing an average annual growth rate of 27% since the start of the Eleventh Five-Year Plan. Miao Wei noted that nearly all commonly used, high‑volume clinical medical devices have now been localized, and breakthroughs have been made in the research, development, and production of several high‑end medical devices. Miao Wei stated that, to further boost the development of the domestic medical device industry, a proactive incentive mechanism for the use of domestically produced medical devices will be established. Miao Wei revealed that, for large-scale equipment developed independently in China—not limited to medical devices—he plans to explore the establishment of a liability insurance scheme specifically designed to support the localization of the first units of major equipment. According to Miao Wei, the China Insurance Regulatory Commission will introduce a new type of insurance policy: participating companies would only need to bear a small portion of the premiums, while the central government would cover the vast majority—estimated to exceed two-thirds—thereby promoting the wider adoption and deployment of the first units and initial batches of domestically produced large-scale equipment. In addition, in May of this year, the National Health and Family Planning Commission issued a notice entrusting the China Medical Equipment Association with launching the selection process for the first batch of outstanding domestically produced medical devices. The selection will encompass three categories: instruments and equipment, medical devices, and consumables. Zhu Qingsheng, Chairman of the China Medical Equipment Association, announced that the list of the first batch of excellent domestically produced devices will soon be released. A second round of selections for outstanding domestic devices is also scheduled to take place in the second half of the year.

Source:

Views:

208

29

2020-07

< 1...5678 > proceed page